The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies

M. S. Van Der Veer*, M. De Weers, B. Van Kessel, J. M. Bakker, S. Wittebol, P. W H I Parren, H. M. Lokhorst, T. Mutis

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Article numbere41
JournalBlood cancer journal
Volume1
Issue number10
DOIs
Publication statusPublished - 1 Oct 2011

Cite this

Van Der Veer, M. S., De Weers, M., Van Kessel, B., Bakker, J. M., Wittebol, S., Parren, P. W. H. I., ... Mutis, T. (2011). The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies. Blood cancer journal, 1(10), [e41]. https://doi.org/10.1038/bcj.2011.42